tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Justin Walsh, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).
Analyst Justin Walsh, currently employed at JONESTRADING, carries an average stock price target met ratio of 44.76% that have a potential upside of 63.71% achieved within 104 days.
Justin Walsh’s has documented 81 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on LNTH, Lantheus Holdings at 09-Jul-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 9/12/2024. The price target of $9 was fulfilled within 42 days with a profit of $5.05 (127.85%) receiving and performance score of 30.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Aug-2025
$12
$5.98 (99.34%)
$12
2 months 22 days ago
(22-Jun-2026)
0/5 (0%)
$6.9 (135.29%)
Buy Since 23-Jun-2021
$11
$4.98 (82.72%)
$11
1 years 9 months 9 days ago
(04-Dec-2024)
0/7 (0%)
$6.47 (142.83%)
Buy Since 16-Apr-2024
$20
$13.98 (232.23%)
$20
1 years 11 months 3 days ago
(10-Oct-2024)
0/3 (0%)
$15.05 (304.04%)
Buy Since 17-Sep-2020
$11
$7.51 (215.19%)
2 years 6 months 8 days ago
(05-Mar-2024)
0/3 (0%)
$6.61 (150.57%)
Buy Since 20-Aug-2018
2 years 9 months 1 days ago
(12-Dec-2023)
3/3 (100%)
$-38 (-65.52%)
360
Which stock is Justin Walsh most bullish on?
Which stock is Justin Walsh most reserved on?
What Year was the first public recommendation made by Justin Walsh?
